Indicators of EOL care quality among Medicare beneficiaries with leukemia, stratified by transfusion dependence and use of hospice at the end of life. (A) Proportions of patients dying in the inpatient setting, with an ICU admission in the last 30 days of life, or with chemotherapy administration in the last 14 days of life. (B) Median Medicare spending in the last 30 days of life (error bars indicate IQR).